beti-cel

bluebird bio Scores First U.S. Approval for Lentiviral Vector Gene Therapy
BioSpace
Wed, 08/17/22 - 11:34 pm
Bluebird Bio
FDA
gene therapy
beta thalassemia
Zynteglo
beti-cel
bluebird bio Soars as FDA Adcom Recommends Second Gene Therapy
BioSpace
Sun, 06/12/22 - 08:30 pm
Bluebird Bio
FDA
lentiviral vectors
beti-cel
Ahead of 2-day adcomm, FDA sounds positive on one bluebird gene therapy but questions remain for another
Endpoints
Tue, 06/7/22 - 10:08 am
FDA
Bluebird Bio
gene therapy
eli-cel
beti-cel
Even at $2M+, ICER calls bluebird's potential gene therapy for blood disorder 'superior' to standard of care
Endpoints
Thu, 06/2/22 - 10:22 am
Bluebird Bio
ICER
gene therapy
FDA
beti-cel
ICER says bluebird bio’s $2.1m gene therapy is cost-effective
Pharmaforum
Thu, 04/14/22 - 10:36 am
Bluebird Bio
ICER
beti-cel
FDA
Feeling Blue: bluebird bio cuts staff by 30%, prepares for FDA decision
BioSpace
Tue, 04/5/22 - 11:55 am
Bluebird Bio
FDA
layoffs
restructuring
eli-cel
beti-cel
bluebird says future uncertain as delays to gene therapies bite
Pharmaforum
Sun, 03/6/22 - 11:18 pm
Bluebird Bio
gene therapy
beti-cel
eli-cel
lovo-cel
No stranger to headwinds, bluebird runs into two PDUFA delays unrelated to new safety issues
Endpoints
Tue, 01/18/22 - 10:40 am
Bluebird Bio
beti-cel
eli-cel
FDA
gene therapy
beta thalassemia
JPM 2022: Bluebird bio hopes for clear skies ahead as it gears up for trio of gene therapy launches
Fierce Pharma
Thu, 01/13/22 - 10:32 pm
JPMHC 2022
Bluebird Bio
gene therapy
sickle cell disease
beti-cel